Entasis Therapeutics Stock Price

0.25 (9.88%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Entasis Therapeutics Holdings Inc ETTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.25 9.88% 2.78 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.59 2.52 2.75 2.64 2.53
Bid Price Ask Price Spread News
2.57 2.85 0.28 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,029 854,424 $ 2.65 $ 2,261,129 864,223 1.58 - 5.64
Last Trade Time Type Quantity Stock Price Currency
19:51:09 formt 230 $ 2.78 USD

Entasis Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 98.62M 35.48M 28.07M $ 7.00M $ - -3.34 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 0.10%

more financials information »

Entasis Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ETTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.612.752.2752.48397,3060.176.51%
1 Month2.452.932.072.49511,7870.3313.47%
3 Months1.812.931.582.01735,8670.9753.59%
6 Months3.144.301.582.16493,085-0.36-11.46%
1 Year4.825.641.582.27284,816-2.04-42.32%
3 Years13.4513.701.582.93142,266-10.67-79.33%
5 Years13.4513.701.582.93142,266-10.67-79.33%

Entasis Therapeutics Description

Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes Zoliflodacin, ETX0282CPDP, and NBP program.

Your Recent History
Entasis Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.